Literature DB >> 7509358

Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb.

P Melotti1, D H Ku, B Calabretta.   

Abstract

The CD34 antigen defines a subset of hematopoietic progenitor cells with self-renewal capacity and the ability to reconstitute hematopoiesis in irradiated primates and marrow-ablated humans, but its function remains unknown. The c-myb protooncogene plays a fundamental role in hematopoiesis, most likely via its transcriptional regulator function. We report that c-myb protein transactivates the CD34 promoter via specific interaction with multiple Myb binding sites in the 5' flanking region of the gene and induces expression of the endogenous CD34 mRNA in rodent fibroblasts. Also, constitutive expression of c-myb in CD34-negative human glioblastoma cells induces expression of CD34 mRNA and synthesis of the surface membrane antigen. These data directly demonstrate that c-myb regulates the expression of the hematopoietic stem cell antigen CD34 and raise the possibility that c-myb regulates hematopoiesis inducing a cascade of differentiation-related events.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509358      PMCID: PMC2191394          DOI: 10.1084/jem.179.3.1023

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  The human CD34 hematopoietic stem cell antigen promoter and a 3' enhancer direct hematopoietic expression in tissue culture.

Authors:  T C Burn; A B Satterthwaite; D G Tenen
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

2.  Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells.

Authors:  D L Simmons; A B Satterthwaite; D G Tenen; B Seed
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  Isolation and molecular characterization of the human CD34 gene.

Authors:  X Y He; V P Antao; D Basila; J C Marx; B R Davis
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

4.  Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells.

Authors:  T McClanahan; S Dalrymple; M Barkett; F Lee
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

5.  Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.

Authors:  R J Berenson; W I Bensinger; R S Hill; R G Andrews; J Garcia-Lopez; D F Kalamasz; B J Still; G Spitzer; C D Buckner; I D Bernstein
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

6.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis.

Authors:  M L Mucenski; K McLain; A B Kier; S H Swerdlow; C M Schreiner; T A Miller; D W Pietryga; W J Scott; S S Potter
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

7.  Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.

Authors:  S A Ness; E Kowenz-Leutz; T Casini; T Graf; A Leutz
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

8.  c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene.

Authors:  D H Ku; S C Wen; A Engelhard; N C Nicolaides; K E Lipson; T A Marino; B Calabretta
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

9.  CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro.

Authors:  D Delia; M G Lampugnani; M Resnati; E Dejana; A Aiello; E Fontanella; D Soligo; M A Pierotti; M F Greaves
Journal:  Blood       Date:  1993-02-15       Impact factor: 22.113

10.  Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb.

Authors:  C Szczylik; T Skorski; D H Ku; N C Nicolaides; S C Wen; L Rudnicka; A Bonati; L Malaguarnera; B Calabretta
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  20 in total

1.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

Authors:  Mo A Dao; Jan A Nolta
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

Review 2.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

3.  c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.

Authors:  A A Postigo; A M Sheppard; M L Mucenski; D C Dean
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

4.  Phenotypic and morphological characterization of neuroblastoma cells constitutively expressing B-myb.

Authors:  S Scarpa; A Negroni; R Amendola; P Signorelli; B Calabretta; A Modesti; G Raschellà
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 5.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

6.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

7.  c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer.

Authors:  C Hernandez-Munain; M S Krangel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.

Authors:  C H Woo; L Sopchak; J S Lipsick
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.

Authors:  P Salomoni; D Perrotti; R Martinez; C Franceschi; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.

Authors:  Maria Rosa Lidonnici; Francesca Corradini; Todd Waldron; Timothy P Bender; Bruno Calabretta
Journal:  Blood       Date:  2008-01-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.